Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report

Farrah J. Mateen, Aminah Jatoi, Timothy W. Lineberry, Dawn Aranguren, Edward T. Creagan, Gary A. Croghan, James R. Jett, Randolph Stuart Marks, Julian R Molina, Ronald L. Richardson

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: Patients with schizophrenia sometimes receive substandard medical care. This study explored such disparities among lung cancer patients with underlying schizophrenia. Methods: This retrospective study focused on patients with pre-existing schizophrenia (or in some instances schizoaffective disorder) and a lung cancer diagnosis made between 1980 and 2004. 'Disparity' was defined as a patient's having been prescribed less aggressive therapy for a potentially curable cancer based on state-of-the-art treatment standards for the time and for the cancer stage. Qualitative methods were used to assess healthcare providers' decision-making. Results: 29 patients were included. The median age was 59 years; 38% were men. Twenty-three had non-small cell lung cancer and 6 small cell lung cancer; 17 had potentially curable cancers. Five of 17 had a 'disparity' in cancer care: (1) no cancer therapy was prescribed because of chronic obstructive pulmonary disease; (2) no cancer therapy was prescribed because of infection; (3) no chemotherapy was prescribed because the patient declined it; radiation was provided; (4) no chemotherapy was prescribed because of the patient's schizophrenia symptoms; radiation was administered; and (5) no surgery was performed because of disorientation from a lobotomy; radiation was prescribed. Comments from healthcare providers suggest reflection and ethical adjudication in decision-making. Conclusion: Schizophrenia was never the sole reason for no cancer treatment in patients with potentially curable lung cancer. This study provides the impetus for others to begin to assess the effect of schizophrenia on lung cancer management in other healthcare settings.

Original languageEnglish (US)
Pages (from-to)721-725
Number of pages5
JournalPsycho-Oncology
Volume17
Issue number7
DOIs
StatePublished - Jul 2008

Fingerprint

schizophrenia
Lung Neoplasms
Schizophrenia
cancer
Neoplasms
Therapeutics
Radiation
Health Personnel
Decision Making
Psychosurgery
Drug Therapy
Confusion
Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
Psychotic Disorders
Chronic Obstructive Pulmonary Disease
disorientation
decision making
Retrospective Studies
Delivery of Health Care

Keywords

  • Disparities
  • Lung cancer
  • Schizophrenia

ASJC Scopus subject areas

  • Oncology
  • Psychology(all)
  • Social Sciences (miscellaneous)

Cite this

Mateen, F. J., Jatoi, A., Lineberry, T. W., Aranguren, D., Creagan, E. T., Croghan, G. A., ... Richardson, R. L. (2008). Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. Psycho-Oncology, 17(7), 721-725. https://doi.org/10.1002/pon.1303

Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. / Mateen, Farrah J.; Jatoi, Aminah; Lineberry, Timothy W.; Aranguren, Dawn; Creagan, Edward T.; Croghan, Gary A.; Jett, James R.; Marks, Randolph Stuart; Molina, Julian R; Richardson, Ronald L.

In: Psycho-Oncology, Vol. 17, No. 7, 07.2008, p. 721-725.

Research output: Contribution to journalArticle

Mateen, FJ, Jatoi, A, Lineberry, TW, Aranguren, D, Creagan, ET, Croghan, GA, Jett, JR, Marks, RS, Molina, JR & Richardson, RL 2008, 'Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report', Psycho-Oncology, vol. 17, no. 7, pp. 721-725. https://doi.org/10.1002/pon.1303
Mateen, Farrah J. ; Jatoi, Aminah ; Lineberry, Timothy W. ; Aranguren, Dawn ; Creagan, Edward T. ; Croghan, Gary A. ; Jett, James R. ; Marks, Randolph Stuart ; Molina, Julian R ; Richardson, Ronald L. / Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report. In: Psycho-Oncology. 2008 ; Vol. 17, No. 7. pp. 721-725.
@article{d14cb8a3864a49c5a3ae4a4e356a6c4f,
title = "Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report",
abstract = "Objective: Patients with schizophrenia sometimes receive substandard medical care. This study explored such disparities among lung cancer patients with underlying schizophrenia. Methods: This retrospective study focused on patients with pre-existing schizophrenia (or in some instances schizoaffective disorder) and a lung cancer diagnosis made between 1980 and 2004. 'Disparity' was defined as a patient's having been prescribed less aggressive therapy for a potentially curable cancer based on state-of-the-art treatment standards for the time and for the cancer stage. Qualitative methods were used to assess healthcare providers' decision-making. Results: 29 patients were included. The median age was 59 years; 38{\%} were men. Twenty-three had non-small cell lung cancer and 6 small cell lung cancer; 17 had potentially curable cancers. Five of 17 had a 'disparity' in cancer care: (1) no cancer therapy was prescribed because of chronic obstructive pulmonary disease; (2) no cancer therapy was prescribed because of infection; (3) no chemotherapy was prescribed because the patient declined it; radiation was provided; (4) no chemotherapy was prescribed because of the patient's schizophrenia symptoms; radiation was administered; and (5) no surgery was performed because of disorientation from a lobotomy; radiation was prescribed. Comments from healthcare providers suggest reflection and ethical adjudication in decision-making. Conclusion: Schizophrenia was never the sole reason for no cancer treatment in patients with potentially curable lung cancer. This study provides the impetus for others to begin to assess the effect of schizophrenia on lung cancer management in other healthcare settings.",
keywords = "Disparities, Lung cancer, Schizophrenia",
author = "Mateen, {Farrah J.} and Aminah Jatoi and Lineberry, {Timothy W.} and Dawn Aranguren and Creagan, {Edward T.} and Croghan, {Gary A.} and Jett, {James R.} and Marks, {Randolph Stuart} and Molina, {Julian R} and Richardson, {Ronald L.}",
year = "2008",
month = "7",
doi = "10.1002/pon.1303",
language = "English (US)",
volume = "17",
pages = "721--725",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report

AU - Mateen, Farrah J.

AU - Jatoi, Aminah

AU - Lineberry, Timothy W.

AU - Aranguren, Dawn

AU - Creagan, Edward T.

AU - Croghan, Gary A.

AU - Jett, James R.

AU - Marks, Randolph Stuart

AU - Molina, Julian R

AU - Richardson, Ronald L.

PY - 2008/7

Y1 - 2008/7

N2 - Objective: Patients with schizophrenia sometimes receive substandard medical care. This study explored such disparities among lung cancer patients with underlying schizophrenia. Methods: This retrospective study focused on patients with pre-existing schizophrenia (or in some instances schizoaffective disorder) and a lung cancer diagnosis made between 1980 and 2004. 'Disparity' was defined as a patient's having been prescribed less aggressive therapy for a potentially curable cancer based on state-of-the-art treatment standards for the time and for the cancer stage. Qualitative methods were used to assess healthcare providers' decision-making. Results: 29 patients were included. The median age was 59 years; 38% were men. Twenty-three had non-small cell lung cancer and 6 small cell lung cancer; 17 had potentially curable cancers. Five of 17 had a 'disparity' in cancer care: (1) no cancer therapy was prescribed because of chronic obstructive pulmonary disease; (2) no cancer therapy was prescribed because of infection; (3) no chemotherapy was prescribed because the patient declined it; radiation was provided; (4) no chemotherapy was prescribed because of the patient's schizophrenia symptoms; radiation was administered; and (5) no surgery was performed because of disorientation from a lobotomy; radiation was prescribed. Comments from healthcare providers suggest reflection and ethical adjudication in decision-making. Conclusion: Schizophrenia was never the sole reason for no cancer treatment in patients with potentially curable lung cancer. This study provides the impetus for others to begin to assess the effect of schizophrenia on lung cancer management in other healthcare settings.

AB - Objective: Patients with schizophrenia sometimes receive substandard medical care. This study explored such disparities among lung cancer patients with underlying schizophrenia. Methods: This retrospective study focused on patients with pre-existing schizophrenia (or in some instances schizoaffective disorder) and a lung cancer diagnosis made between 1980 and 2004. 'Disparity' was defined as a patient's having been prescribed less aggressive therapy for a potentially curable cancer based on state-of-the-art treatment standards for the time and for the cancer stage. Qualitative methods were used to assess healthcare providers' decision-making. Results: 29 patients were included. The median age was 59 years; 38% were men. Twenty-three had non-small cell lung cancer and 6 small cell lung cancer; 17 had potentially curable cancers. Five of 17 had a 'disparity' in cancer care: (1) no cancer therapy was prescribed because of chronic obstructive pulmonary disease; (2) no cancer therapy was prescribed because of infection; (3) no chemotherapy was prescribed because the patient declined it; radiation was provided; (4) no chemotherapy was prescribed because of the patient's schizophrenia symptoms; radiation was administered; and (5) no surgery was performed because of disorientation from a lobotomy; radiation was prescribed. Comments from healthcare providers suggest reflection and ethical adjudication in decision-making. Conclusion: Schizophrenia was never the sole reason for no cancer treatment in patients with potentially curable lung cancer. This study provides the impetus for others to begin to assess the effect of schizophrenia on lung cancer management in other healthcare settings.

KW - Disparities

KW - Lung cancer

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=48449084069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48449084069&partnerID=8YFLogxK

U2 - 10.1002/pon.1303

DO - 10.1002/pon.1303

M3 - Article

C2 - 18050362

AN - SCOPUS:48449084069

VL - 17

SP - 721

EP - 725

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 7

ER -